Robert Tungadi
1* , Widy Susanty
1, Prisca Wicita
1, Elvira Pido
11 Department of Pharmacy, Faculty of Sport and Health, State University of Gorontalo, Gorontalo, Indonesia.
Abstract
Background: The aim of the
present study was to characterize and evaluate the nanoemulgel (NEG) of snakehead
fish powder (SFP), as a transdermal delivery system for poorly water soluble
drug, in order to conquer the inconveniences related to its oral conveyance.
Methods: Diverse
nanoemulsion components (oil, surfactant, and co-surfactant) were chosen based
on solvency and emulsification capacity. SFP loaded nanoemulsion which tested
by stress-stability testing was carried out for all formulations and those that
passed these tests were characterized for mean droplet size, polydispersity
index (PDI), zeta potential, pH, viscosity, and transmittance. After that, this
was continued by permeation studies using snake skin in vitro and rabbit skin
in vivo studies i.e. skin irritation study and the effectiveness test.
Results: Mean
droplet size and zeta potential of the optimized nanoemulsion (NE4) were found
to be 98.6 ± 0.93 nm (polydispersity index, PDI = 0.1 ± 0.20) and -57.5 ± 0.3 mV
respectively. Optimized nanoemulsion was converted into nanoemulgel with 1.5%
w/v of gelling agent (HPMC) and evaluated for pH, viscosity, spreadability, and
extrudability measurement. Ex vivo transdermal permeation value for SFP through
snake skin as membrane from NEG1, NEG2, NEG3
and marketed SFP cream showed results of 55.65 ± 0.93%, 56.14 ± 0.70%, 66.75 ±
1.03% and 49.80 ± 3.42% respectively in 3 hours. Moreover, all the treatment
group did not show skin irritation of each group. The effect of burn wound
healing of NEG3 showed a significant (P<0.05) on the measurement of wound
area compared to marketed cream.
Conclusion: The
novel NEG of SFP was successfully formulated for transdermal application based
on the results of evaluations and stability tests on accelerating burn wound
healing.